A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy®

NCT06633783 PHASE3 NOT_YET_RECRUITING

The purpose of the study is to compare the effect on body weight in subjects taking semaglutide injection or subjects taking Wegovy®.

Details

Lead sponsor	Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
Phase	PHASE3
Status	NOT_YET_RECRUITING
Enrolment	370
Start date	Wed Oct 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Oct 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Obesity

Interventions

• Semaglutide
• Semaglutide

Countries

China